• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在哥伦比亚,测试多标准决策分析以实现更透明的资源分配决策

TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.

作者信息

Castro Jaramillo Hector Eduardo, Goetghebeur Mireille, Moreno-Mattar Ornella

机构信息

T.H. Chan Harvard School of Public Health,Global Health & Population,Bogotá,Colombia.

LASER ANALYTICA,Montreal and School of Public Health,University of Montreal,Montreal,Quebec,Canada.

出版信息

Int J Technol Assess Health Care. 2016 Jan;32(4):307-314. doi: 10.1017/S0266462316000350. Epub 2016 Oct 3.

DOI:10.1017/S0266462316000350
PMID:27691990
Abstract

OBJECTIVES

In 2012, Colombia experienced an important institutional transformation after the establishment of the Health Technology Assessment Institute (IETS), the disbandment of the Regulatory Commission for Health and the reassignment of reimbursement decision-making powers to the Ministry of Health and Social Protection (MoHSP). These dynamic changes provided the opportunity to test Multi-Criteria Decision Analysis (MCDA) for systematic and more transparent resource-allocation decision-making.

METHODS

During 2012 and 2013, the MCDA framework Evidence and Value: Impact on Decision Making (EVIDEM) was tested in Colombia. This consisted of a preparatory stage in which the investigators conducted literature searches and produced HTA reports for four interventions of interest, followed by a panel session with decision makers. This method was contrasted with a current approach used in Colombia for updating the publicly financed benefits package (POS), where narrative health technology assessment (HTA) reports are presented alongside comprehensive budget impact analyses (BIAs).

RESULTS

Disease severity, size of population, and efficacy ranked at the top among fifteen preselected relevant criteria. MCDA estimates of technologies of interest ranged between 71 to 90 percent of maximum value. The ranking of technologies was sensitive to the methods used. Participants considered that a two-step approach including an MCDA template, complemented by a detailed BIA would be the best approach to assist decision-making in this context. Participants agreed that systematic priority setting should take place in Colombia.

CONCLUSIONS

This work may serve as the basis to the MoHSP on its interest of setting up a systematic and more transparent process for resource-allocation decision-making.

摘要

目标

2012年,哥伦比亚在卫生技术评估研究所(IETS)成立、卫生监管委员会解散以及报销决策权重新分配给卫生和社会保障部(MoHSP)之后,经历了一次重要的制度变革。这些动态变化为测试多标准决策分析(MCDA)以进行系统且更透明的资源分配决策提供了机会。

方法

2012年至2013年期间,MCDA框架“证据与价值:对决策的影响”(EVIDEM)在哥伦比亚进行了测试。这包括一个准备阶段,在此阶段研究人员进行文献检索并为四项感兴趣的干预措施撰写卫生技术评估(HTA)报告,随后与决策者举行小组会议。该方法与哥伦比亚目前用于更新公共资助福利包(POS)的方法形成对比,后者在提供叙述性卫生技术评估(HTA)报告的同时还提供全面的预算影响分析(BIA)。

结果

在预先选定的15项相关标准中,疾病严重程度、人口规模和疗效位列前三。对感兴趣技术的MCDA估计值在最大值的71%至90%之间。技术排名对所使用的方法很敏感。参与者认为,包括MCDA模板并辅以详细BIA的两步法是在此背景下协助决策的最佳方法。参与者一致认为哥伦比亚应进行系统的优先级设定。

结论

这项工作可为卫生和社会保障部建立系统且更透明的资源分配决策流程提供依据。

相似文献

1
TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.在哥伦比亚,测试多标准决策分析以实现更透明的资源分配决策
Int J Technol Assess Health Care. 2016 Jan;32(4):307-314. doi: 10.1017/S0266462316000350. Epub 2016 Oct 3.
2
Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.将健康技术评估(HTA)与多准则决策分析(MCDA)相结合,以实现高效的医疗保健决策:将 EVIDEM 框架应用于药品评估。
Med Decis Making. 2012 Mar-Apr;32(2):376-88. doi: 10.1177/0272989X11416870. Epub 2011 Oct 10.
3
Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.用于医疗保健决策的多标准决策分析——简介:ISPOR多标准决策分析新兴良好实践工作组报告1
Value Health. 2016 Jan;19(1):1-13. doi: 10.1016/j.jval.2015.12.003. Epub 2016 Jan 8.
4
HTA and MCDA solely or combined? The case of priority-setting in Colombia.卫生技术评估与多标准决策分析单独使用还是联合使用?以哥伦比亚的优先事项设定为例。
Cost Eff Resour Alloc. 2018 Nov 9;16(Suppl 1):47. doi: 10.1186/s12962-018-0127-6. eCollection 2018.
5
The Use of MCDA in HTA: Great Potential, but More Effort Needed.多准则决策分析在卫生技术评估中的应用:潜力巨大,但仍需努力。
Value Health. 2018 Apr;21(4):394-397. doi: 10.1016/j.jval.2017.10.001. Epub 2017 Nov 22.
6
Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.运用多标准决策分析在医疗保健领域做出明智决策:多标准决策分析的应用、当前研究与未来发展
Appl Health Econ Health Policy. 2016 Feb;14(1):29-40. doi: 10.1007/s40258-015-0203-4.
7
Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.用于卫生技术评估的多标准决策分析(MCDA):昆士兰卫生部门的经验
Aust Health Rev. 2019 Oct;43(5):591-599. doi: 10.1071/AH18042.
8
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.将卫生技术评估 (HTA) 与多准则决策分析 (MCDA) 相结合:在加拿大,对公共支付方进行覆盖决策的 EVIDEM 框架进行现场测试。
BMC Health Serv Res. 2011 Nov 30;11:329. doi: 10.1186/1472-6963-11-329.
9
EMERGENCE OF "DRIVERS" FOR THE IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT.卫生技术评估实施中“驱动因素”的出现
Int J Technol Assess Health Care. 2016 Jan;32(4):300-306. doi: 10.1017/S0266462316000404. Epub 2016 Oct 3.
10
Relevance of barriers and facilitators in the use of health technology assessment in Colombia.哥伦比亚卫生技术评估使用中障碍与促进因素的相关性
J Med Econ. 2018 May;21(5):510-517. doi: 10.1080/13696998.2018.1449751. Epub 2018 Mar 23.

引用本文的文献

1
Design of a multiple criteria decision analysis framework for prioritizing high-impact health technologies in a regional health service.用于对区域卫生服务中具有高影响力的卫生技术进行优先排序的多标准决策分析框架设计
Int J Technol Assess Health Care. 2024 Apr 5;40(1):e21. doi: 10.1017/S0266462324000205.
2
Priority setting in cardiovascular research in Iran using standard indigenous methods.运用标准本土方法确定伊朗心血管研究的优先事项。
J Res Med Sci. 2022 Dec 23;27:91. doi: 10.4103/jrms.jrms_343_22. eCollection 2022.
3
What Does the Public Want? Structural Consideration of Citizen Preferences in Health Care Coverage Decisions.
公众想要什么?医疗保健覆盖决策中公民偏好的结构考量。
MDM Policy Pract. 2018 Sep 25;3(2):2381468318799628. doi: 10.1177/2381468318799628. eCollection 2018 Jul-Dec.
4
Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries-A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses.支持中高收入国家创新药物评估的框架潜在标准——关于价值框架和多标准决策分析的系统文献综述
Front Pharmacol. 2020 Aug 14;11:1203. doi: 10.3389/fphar.2020.01203. eCollection 2020.
5
Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis.非酒精性脂肪性肝炎药物研发中的早期卫生技术评估:两轮跨国多标准决策分析。
Med Decis Making. 2020 Aug;40(6):830-845. doi: 10.1177/0272989X20940672.
6
Multi-criteria Decision Analysis Software in Healthcare Priority Setting: A Systematic Review.多准则决策分析软件在医疗保健优先级设置中的应用:系统评价。
Pharmacoeconomics. 2020 Mar;38(3):269-283. doi: 10.1007/s40273-019-00863-9.
7
Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art.多准则决策分析在卫生技术评估中的应用:应对方法学挑战,提升现有技术水平。
Eur J Health Econ. 2019 Aug;20(6):891-918. doi: 10.1007/s10198-019-01052-3. Epub 2019 Apr 20.
8
Can reflective multicriteria be the new paradigm for healthcare decision-making? The EVIDEM journey.反思性多标准能否成为医疗保健决策的新范式?EVIDEM之旅。
Cost Eff Resour Alloc. 2018 Nov 9;16(Suppl 1):54. doi: 10.1186/s12962-018-0116-9. eCollection 2018.
9
HTA and MCDA solely or combined? The case of priority-setting in Colombia.卫生技术评估与多标准决策分析单独使用还是联合使用?以哥伦比亚的优先事项设定为例。
Cost Eff Resour Alloc. 2018 Nov 9;16(Suppl 1):47. doi: 10.1186/s12962-018-0127-6. eCollection 2018.
10
Authors' Reply to Gandjour: "Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation".作者对甘德久尔的回复:“EVIDEM框架能否解决评估罕见病治疗方法所引发的问题:问题与政策分析以及因地制宜的调整”
Pharmacoeconomics. 2017 May;35(5):605-606. doi: 10.1007/s40273-017-0498-0.